Skip to main content

Notification · DGFT

NOTIFICATION NO. 50/2021, DT. 10/01/2022

Dated
10 Jan 2022

Amendment in Export Policy of Enoxaparin (formulation and API) and Intra-Venous Immunoglobulin (IVIG) (formulation and API) – regarding

NOTIFICATION NO. 50/2021, DT. 10/01/2022

Amendment in Export Policy of Enoxaparin (formulation and API) and Intra-Venous Immunoglobulin (IVIG) (formulation and API) – regarding

 

S.O. 93(E) In exercise of powers conferred by Section 3 read with Section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy. 2015-20. the Central Government hereby makes the following amendment in Chapter 29 and 30 of Schedule 2 of the ITCHS Export policy 2018 related to export of Enoxaparin and Intra-Venous Immunoglobulin (IVIG):
 

S.No ITC HS Codes Description Present Policy Revised Policy
207AE Ex2942
Ex3001
Ex3002
Enoxaparin (Formulation and API) Free Restricted
207AF Ex3002 Intra-Venous Immunoglobulin (IVIG) (Formulation and API) Free Restricted


2. Effect of this Notification:

The export of Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under the ITC (HS) Codes specified above or falling under any other HS Code has been put under restricted category, with immediate effect.
 

(Amit Yadav)
Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India
E-mail: dgft@nic.in

(Issued from File No. 01/91/180/021/AM22/EC/E-30431)